Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Regenerative medicine in Malaysia shows promise for treating diseases but faces ethical and safety challenges.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.